Core Laboratories (CLB)
NYSEEnergyOil & Gas Equipment & ServicesSnapshot 2026-07-23
Reading CLB? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →NYSEEnergyOil & Gas Equipment & ServicesSnapshot 2026-07-23
Reading CLB? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a cautious view on a company in the energy sector, which is currently facing mixed performance and elevated risks. The thesis is in a watch state, indicating that while there are some positive aspects, the overall execution has been weak.
The current valuation suggests that the market sees CLB as relatively cheap compared to its peers, with a slight expectations gap. However, the fragility of its earnings quality and the turbulent sector conditions indicate that the market is not fully pricing in potential risks.
Management has emphasized operational efficiency and revenue growth, but recent results show limited progress in these areas. The near-term risk of missing earnings is notable, with a 43% probability, which could further impact the company's performance.
The thesis hinges on several factors, including inflation trends that could benefit the energy sector, the performance of sector leaders, and the company's ability to meet its guidance. A cut in guidance would be a significant negative trigger.
Over the next 1 to 3 years, CLB's performance will depend on external economic factors and internal execution improvements. Not investment advice.
The most important moves since the prior daily snapshot.
Valuation fell by 11.7 points (from 60.0 to 48.3).
Yes, our read has weakened. The latest earnings report missed expectations. This miss raises concerns about the company's performance. There are no new strengths to support a positive outlook.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Ongoing issues in the Middle East can hurt revenue and operations. Keeping an eye on this is important.
Confirms:No new problems reported in Middle East operations. These do not affect revenue or project schedules.
Disproves:More problems reported in Middle East operations. These affect revenue and project schedules.
Why it matters: If revenue guidance is below $119 million, it shows client issues. This confirms problems from conflicts and disruptions.
Confirms:Q2 2026 revenue guidance issued below $119 million.
Disproves:Q2 2026 revenue guidance issued at or above $123 million.
Why it matters: Better efficiency helps make more money. This can make investors feel more confident.
Confirms:Operating income for Q2 2026 shows a sequential increase from Q1 2026's $1.9M.
Disproves:Operating income for Q2 2026 drops or stays below $1.9M.
Why it matters: Earnings per share meeting guidance shows financial health and good management. This can help market views.
Confirms:Q2 2026 EPS meets or exceeds the guidance range of $0.05 to $0.07.
Disproves:Q2 2026 EPS falls below the guidance range of $0.05 to $0.07.
Why it matters: Free cash flow trends show the company's financial health and ability to pay dividends.
Confirms one read:Free cash flow for Q2 2026 is over $1 million. This shows better cash generation.
Confirms the other:Free cash flow for Q2 2026 drops below $0.5 million, signaling cash flow challenges.
Why it matters: More share buybacks show management's confidence in the company and a promise to return value.
Confirms:Core Lab announces share repurchases exceeding $900,000 in Q2 2026.
Disproves:Core Lab will not do share buybacks in Q2 2026. This shows worries about cash flow.
Why it matters: Earnings per share above this level shows a recovery in profit and performance.
Confirms:Q2 2026 EPS is over $0.07. This shows profit is improving despite challenges.
Disproves:Q2 2026 EPS is below $0.05. This shows ongoing problems with making a profit.